October 24, 2026
Pathos AI
Pathos AI uses artificial intelligence to license clinical assets and optimize drug trial design.
- Round
- Series E
- Amount raised
- $237M
- Lead investor
- Bristol Myers Squibb
- Industry
- Biotechnology
- Headquarters
- Chicago
- Employees
- 11-50 employees
- Website
- pathos.com
- View profile →